ArticleACS medicinal chemistry letters2015

Discovery of VU0409551/JNJ-46778212: An mGlu5 Positive Allosteric Modulator Clinical Candidate Targeting Schizophrenia.

Susana Conde-Ceide et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.